| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute-phase reaction induced by zoledronate and its effect on prognosis of patients with advanced non-small cell lung cancer
|
Izumi, Hiroki
|
|
|
122 |
C |
p. 200-205
|
artikel
|
| 2 |
Aims and Scope/Editorial Board
|
|
|
|
122 |
C |
p. iii
|
artikel
|
| 3 |
Akt/PKB signaling regulates cigarette smoke-induced pulmonary epithelial-mesenchymal transition
|
Jiang, Bo
|
|
|
122 |
C |
p. 44-53
|
artikel
|
| 4 |
Are intra-pleural bacterial products associated with longer survival in adults with malignant pleural effusions? A systematic review
|
Bibby, Anna C.
|
|
|
122 |
C |
p. 249-256
|
artikel
|
| 5 |
Assessing the completeness and correctness of the registration of malignant mesothelioma in Belgium
|
Rosskamp, Michael
|
|
|
122 |
C |
p. 38-43
|
artikel
|
| 6 |
Association between hospital volume and mortality of patients with metastatic non-small cell lung cancer
|
Goyal, Gaurav
|
|
|
122 |
C |
p. 214-219
|
artikel
|
| 7 |
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer
|
Chaft, Jamie E.
|
|
|
122 |
C |
p. 67-71
|
artikel
|
| 8 |
Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study
|
Lee, Yun-Gyoo
|
|
|
122 |
C |
p. 88-93
|
artikel
|
| 9 |
Comparison of up-front radiotherapy and TKI with TKI alone for NSCLC with brain metastases and EGFR mutation: A meta-analysis
|
Wang, Chunyu
|
|
|
122 |
C |
p. 94-99
|
artikel
|
| 10 |
Contents
|
|
|
|
122 |
C |
p. iv-vi
|
artikel
|
| 11 |
CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium
|
Mu, Luwen
|
|
|
122 |
C |
p. 25-31
|
artikel
|
| 12 |
Disparities in lung cancer survival and receipt of surgical treatment
|
Osuoha, Chima A.
|
|
|
122 |
C |
p. 54-59
|
artikel
|
| 13 |
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial
|
Hallqvist, Andreas
|
|
|
122 |
C |
p. 180-186
|
artikel
|
| 14 |
Effects of crizotinib on creatinine clearance and renal hemodynamics
|
Meijer-Schaap, Lysbert
|
|
|
122 |
C |
p. 192-194
|
artikel
|
| 15 |
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma
|
Lee, Jiyun
|
|
|
122 |
C |
p. 160-164
|
artikel
|
| 16 |
Epithelial-to-mesenchymal transition of A549 lung cancer cells exposed to electronic cigarettes
|
Zahedi, Atena
|
|
|
122 |
C |
p. 224-233
|
artikel
|
| 17 |
Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
|
Zhao, Binghao
|
|
|
122 |
C |
p. 10-21
|
artikel
|
| 18 |
Extensive chest wall resection, reconstruction and right pneumonectomy in a 24-week pregnant patient
|
Kapdagli, Murat
|
|
|
122 |
C |
p. 7-9
|
artikel
|
| 19 |
Germline mutations in young non-smoking women with lung adenocarcinoma
|
Donner, Iikki
|
|
|
122 |
C |
p. 76-82
|
artikel
|
| 20 |
Goodpasture’s disease in a patient with advanced lung cancer treated with nivolumab: An autopsy case report
|
Takahashi, Naoki
|
|
|
122 |
C |
p. 22-24
|
artikel
|
| 21 |
30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease
|
Osti, M.F.
|
|
|
122 |
C |
p. 165-170
|
artikel
|
| 22 |
HOXA9 methylation and blood vessel invasion in FFPE tissues for prognostic stratification of stage I lung adenocarcinoma patients
|
Lissa, Delphine
|
|
|
122 |
C |
p. 151-159
|
artikel
|
| 23 |
Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomas
|
Li, Yan
|
|
|
122 |
C |
p. 113-119
|
artikel
|
| 24 |
Induction chemoradiotherapy versus chemotherapy alone for superior sulcus lung cancer
|
Robinson, Lary A.
|
|
|
122 |
C |
p. 206-213
|
artikel
|
| 25 |
Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping
|
Guibert, Nicolas
|
|
|
122 |
C |
p. 72-75
|
artikel
|
| 26 |
Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer
|
Deng, Weiye
|
|
|
122 |
C |
p. 60-66
|
artikel
|
| 27 |
Management of co-existent tuberculosis and lung cancer
|
Ho, James Chung-man
|
|
|
122 |
C |
p. 83-87
|
artikel
|
| 28 |
Next-generation sequencing analysis identifies genomic alterations in pathological morphologies: A case of pulmonary carcinosarcoma harboring EGFR mutations
|
Koba, Hayato
|
|
|
122 |
C |
p. 146-150
|
artikel
|
| 29 |
Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy
|
Lee, Jong Seok
|
|
|
122 |
C |
p. 234-242
|
artikel
|
| 30 |
Nivolumab-induced pneumonitis complicated by cyst formation
|
Gorospe, Luis
|
|
|
122 |
C |
p. 258-259
|
artikel
|
| 31 |
Non-small cell lung cancer transdifferentiation into small cell lung cancer: A case series
|
Ahmed, Tahreem
|
|
|
122 |
C |
p. 220-223
|
artikel
|
| 32 |
Overexpression of endoplasmic reticulum stress-related proteins, XBP1s and GRP78, predicts poor prognosis in pulmonary adenocarcinoma
|
Kwon, Dohee
|
|
|
122 |
C |
p. 131-137
|
artikel
|
| 33 |
Patient-reported symptoms possibly related to treatment with osimertinib or chemotherapy for advanced non-small cell lung cancer
|
Sebastian, Martin
|
|
|
122 |
C |
p. 100-106
|
artikel
|
| 34 |
Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: A population-based study
|
Yap, Sarsha
|
|
|
122 |
C |
p. 171-179
|
artikel
|
| 35 |
Penetration of the blood–brain barrier by avitinib and its control of intra/extra-cranial disease in non-small cell lung cancer harboring the T790M mutation
|
Wang, Hanping
|
|
|
122 |
C |
p. 1-6
|
artikel
|
| 36 |
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer
|
Si, Xiaoyan
|
|
|
122 |
C |
p. 32-37
|
artikel
|
| 37 |
Routine preoperative brain CT in resectable non-small cell lung cancer – Ten years experience from a tertiary UK thoracic center
|
Matys, Tomasz
|
|
|
122 |
C |
p. 195-199
|
artikel
|
| 38 |
Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes
|
Triphuridet, Natthaya
|
|
|
122 |
C |
p. 243-248
|
artikel
|
| 39 |
Second-line therapy and advanced non-small cell lung cancer: What about smoking?
|
Braillon, Alain
|
|
|
122 |
C |
p. 257
|
artikel
|
| 40 |
Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study
|
Inoue, Tetsuya
|
|
|
122 |
C |
p. 107-112
|
artikel
|
| 41 |
Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016
|
Brustugun, Odd Terje
|
|
|
122 |
C |
p. 138-145
|
artikel
|
| 42 |
Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations
|
Wang, Samantha X.Y.
|
|
|
122 |
C |
p. 187-191
|
artikel
|
| 43 |
Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma
|
Eguren-Santamaria, I.
|
|
|
122 |
C |
p. 120-123
|
artikel
|
| 44 |
Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance
|
Millares, Laura
|
|
|
122 |
C |
p. 124-130
|
artikel
|
Tijdschrift beschrijving